Official PDF Translation•Chinese Journal of New Drugs

Adverse Drug Reactions in Cancer Patients: A Systematic Review and Meta-Analysis

Authors: John Smith; Jane Doe; Robert Johnson

DOI: 10.1007/s12345-024-01234-5Status: Verified Translated Edition

Sponsored AdvertisementAd Placement Area

reCAPTCHA Bot Shield Active

Preparing Secure Academic Download

Verifying human reader & generating high-resolution document...

Verifying Document Integrity15s remaining

← Back to Article

Protected by Google reCAPTCHA v3.•Privacy•Terms

Sponsored ContentAdSense In-Feed Ad Slot

Key Findings in This Report

• The overall incidence of adverse drug reactions in cancer patients is 45.2%, with hematologic toxicities being the most common. • Risk factors for ADRs include older age, polypharmacy, and specific chemotherapy regimens. • ADRs significantly increase hospitalization rates and reduce quality of life in cancer patients. • Proactive monitoring and management strategies are critical to mitigate the impact of ADRs in oncology.